Free Disclosure Statement - District Court of Delaware - Delaware

Case 1 :07-cv—00572-GIVIS Document 40 Filed 10/24/2007 Page 1 of 2
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
)
SANOFI-AVENTIS and )
SANOFI-AVENTIS U.S. LLC, )
)
Plaintiffs, )
)
v. )
) C.A. No. 1:07-cv-00572-GMS
ACTAVIS SOUTH ATLANTIC LLC, )
AUROBINDO PHARMA LTD., )
AUROBINDO PHARMA USA INC., )
MYLAN PHARMACEUTICALS INC., )
PAR PHARMACEUTICAL, INC., )
RANBAXY INC., RANBAXY )
LABORATORIES LIMITED, SUN )
PHARMACEUTICAL INDUSTRIES, )
INC., SUN PHARMACEUTICAL )
INDUSTRIES, LTD., TEVA )
PHARMACEUTICALS USA, INC., )
TORRENT PHARMA INC. and )
TORRENT PHARMACEUTICALS )
LIMITED )
)
Defendants. )

DEFENDANT PAR PHARMACEUTICAL, INC.’S
RULE 7.1 CORPORATE DISCLOSURE STATEMENT
Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, Defendant Actavis
South Atlantic LLC states:
l. Par Pharmaceutical, Inc. is a wholly-owned subsidiary of Par
Pharmaceutical Companies, Inc.
2. No publicly held corporation owns 10% or more of Par Pharmaceutical
Companies, Inc.

Case 1:07-cv—00572-Gl\/IS Document 40 Filed 10/24/2007 Page 2 of 2
Dated: October 24, 2007 /s/ Dominick Gattuso
Andre G. Bouchard (No. 2504)
Dominick T. Gattuso (No. 3630)
Boucnmzo, Mmzoures & FMEDLANDER, P.A.
222 Delaware Avenue, Suite 1400
Wilmington, DE 19801
Telephone: (302) 573-3500
[email protected]
1 [email protected]
Attorneys for Dekndant
Par Pharmaceutical, Inc.
OF COUNSEL:
John Will Ongman
Sanjay B. Sitlani
AXINN, VELTROP &
HARKRIDER LLP
1330 Connecticut Avenue, NW
Washington, DC 20036
(202) 912-4700
Chad A. Landmon
AXINN, VELTROP &
HARKRIDER LLP
90 State House Square
Hartford, CT 06103-3702
(860) 275-8100
Attorneys for Defendant
Par Pharmaceutical, Inc.
2

Case 1:07-cv-00572-GMS

Document 40

Filed 10/24/2007

Page 1 of 2

Case 1:07-cv-00572-GMS

Document 40

Filed 10/24/2007

Page 2 of 2